152 related articles for article (PubMed ID: 35146837)
1. Treatment of Candida urinary tract infections with micafungin in children.
Ekinci F; Yildizdas D; Horoz OO; Ozgur Gundeslioglu O; Alabaz D
Pediatr Int; 2022 Jan; 64(1):e15033. PubMed ID: 35146837
[TBL] [Abstract][Full Text] [Related]
2. Micafungin treatment and eradication of candiduria among hospitalized patients.
Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
[TBL] [Abstract][Full Text] [Related]
3. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.
Grau S; Luque S; Echeverría-Esnal D; Sorlí L; Campillo N; Montero M; Álvarez Lerma F; Plasencia V; Horcajada JP
Int J Antimicrob Agents; 2016 Aug; 48(2):212-4. PubMed ID: 27424599
[TBL] [Abstract][Full Text] [Related]
4. Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.
Multani A; Subramanian AK; Liu AY
Transpl Infect Dis; 2019 Aug; 21(4):e13118. PubMed ID: 31111613
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Treatment of Candiduria at an Academic Medical Center.
Radosevich JJ; Nix D; Erstad BL
Am J Ther; 2016; 23(6):e1774-e1780. PubMed ID: 26938759
[TBL] [Abstract][Full Text] [Related]
6. Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study.
Jacobs DM; Dilworth TJ; Beyda ND; Casapao AM; Bowers DR
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109159
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of Micafungin Use in Children].
Yeşil E; Çelebi S; Sezgin Evim M; Özer A; Turan C; Timur D; Çakır SÇ; Bülbül B; Ener B; Güneş AM; Köksal N; Özkan H; Sevinir B; Düzcan Kilimci D; Hacımustafaoğlu M
Mikrobiyol Bul; 2020 Jan; 54(1):120-134. PubMed ID: 32050883
[TBL] [Abstract][Full Text] [Related]
8. Micafungin for Candida infections in Slovenia and Romania: A multicenter, observational, prospective study.
Zver S; Avcin S; Bedreag O; Bizilj S; Ecrulj V; Jazbec J; Puconja N; Stanic R; Jereb M
J Infect Dev Ctries; 2021 Jun; 15(6):877-888. PubMed ID: 34242200
[TBL] [Abstract][Full Text] [Related]
9. [Results of the use of micafungin in newborns].
Çakır SÇ; Çelebi S; Özkan H; Köksal N; Dorum BA; Yeşil E; Hacımustafaoğlu M
Mikrobiyol Bul; 2019 Jan; 53(1):70-80. PubMed ID: 30683041
[TBL] [Abstract][Full Text] [Related]
10. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
[TBL] [Abstract][Full Text] [Related]
12. Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.
Leverger G; Timsit JF; Milpied N; Gachot B
Pediatr Infect Dis J; 2019 Jul; 38(7):716-721. PubMed ID: 31192976
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of micafungin in pediatric immunocompromised patients with invasive fungal infection.
Hashii Y; Kusuki S; Takizawa S; Tokimasa S; Ohta H; Hara J; Ozono K
Pediatr Int; 2014 Dec; 56(6):834-837. PubMed ID: 24730676
[TBL] [Abstract][Full Text] [Related]
14. To treat or not to treat--critically ill patients with candiduria.
Hollenbach E
Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
[TBL] [Abstract][Full Text] [Related]
15. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.
Carter NJ; Keating GM
Paediatr Drugs; 2009; 11(4):271-91. PubMed ID: 19566111
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial.
Kumar S; Bansal A; Chakrabarti A; Singhi S
Crit Care Med; 2013 Feb; 41(2):565-72. PubMed ID: 23361033
[TBL] [Abstract][Full Text] [Related]
17. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L; Kontoyiannis D; Raffalli J; Mullane KM; Vazquez J; Anaissie EJ; Lipton J; Jacobs P; van Rensburg JH; Rex JH; Lau W; Facklam D; Buell DN
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):654-61. PubMed ID: 16261306
[TBL] [Abstract][Full Text] [Related]
18. Clinician response to Candida organisms in the urine of patients attending hospital.
Chen SC; Tong ZS; Lee OC; Halliday C; Playford EG; Widmer F; Kong FR; Wu C; Sorrell TC
Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):201-8. PubMed ID: 18060438
[TBL] [Abstract][Full Text] [Related]
19. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
[TBL] [Abstract][Full Text] [Related]
20. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
